scispace - formally typeset
C

Christel Faes

Researcher at University of Hasselt

Publications -  231
Citations -  4423

Christel Faes is an academic researcher from University of Hasselt. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 30, co-authored 196 publications receiving 3426 citations. Previous affiliations of Christel Faes include Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020.

TL;DR: High estimates of the proportion of pre-symptomatic transmission imply that case finding and contact tracing need to be supplemented by physical distancing measures in order to control the COVID-19 outbreak.
Journal ArticleDOI

Time between symptom onset, hospitalisation and recovery or death: statistical analysis of Belgian COVID-19 patients

TL;DR: The hospital LoS for patients that recover is shorter for patients living in a nursing home, but the time to death is longer for these patients, and over the course of the first wave, the LoS has decreased.
Posted ContentDOI

Estimating the generation interval for COVID-19 based on symptom onset data

TL;DR: Estimating generation and serial interval distributions from outbreak data requires careful investigation of the underlying transmission network, which is essential for correctly estimating these quantities.
Journal ArticleDOI

Chronic exposure of mice to environmentally relevant, low doses of cadmium leads to early renal damage, not predicted by blood or urine cadmium levels

TL;DR: The results indicate that chronic exposure to low doses of Cd induced functional and histological signs of early damage at concentrations in or below the ones generally accepted as safe are indicated.
Journal ArticleDOI

European Surveillance of Antimicrobial Consumption (ESAC): outpatient penicillin use in Europe (1997–2009)

TL;DR: Penicillins represented the most widely used antibiotic subgroup in all 33 participating countries, albeit with considerable variation in their use patterns, and a continuous increase in overall penicillin use and of COP use was observed during the period 1997-2009.